Suppr超能文献

血管紧张素Ⅱ抑制在原发性高血压强化降压治疗中对肾脏的影响。

Renal vascular response to angiotensin II inhibition in intensive antihypertensive treatment of essential hypertension.

机构信息

Department of Internal Medicine, Nephrology and Dialysis, Military Institute of Medicine, Warsaw, Poland.

出版信息

Arch Med Sci. 2010 Aug 30;6(4):533-8. doi: 10.5114/aoms.2010.14464. Epub 2010 Sep 7.

Abstract

INTRODUCTION

High blood pressure (BP) leads to target organ damage. It is suggested that regression of early organ lesions is possible on condition of BP normalization. The study objective was to assess whether permanent reduction of BP to the recommended values modifies renal vascular response to acute angiotensin II inhibition in the Doppler captopril test (DCT) in patients with essential hypertension (EH).

MATERIAL AND METHODS

Twenty-nine persons (58 kidneys) were found eligible for the study: 18 patients with EH and 11 healthy volunteers constituting the control group. Glomerular filtration rate estimation (eGFR), 24-h ambulatory BP monitoring (ABPM) and DCT with evaluation of renal resistive index change (ΔRI) were performed before and after a 6-month period of intensive antihypertensive therapy (IAT). Additional ABPM was performed at the end of IAT.

RESULTS

The mean IAT period was 8.5 ±2.4 months. The mean 24-h values of systolic and diastolic BP in the EH group were significantly lower in the IAT period than at the beginning and at the end of the study. Significantly lower systolic and diastolic BP (p < 0.05) and improvement of renal function (eGFR 121 ±38 vs. 139 ±40 ml/min, p < 0.001) were found after IAT as compared to initial values. Before IAT, ΔRI was significantly lower in the EH group as compared to the controls, but no such differences were found after IAT.

CONCLUSIONS

In EH patients, intensive BP lowering to the recommended values was associated with improvement of renal function and normalisation of renal vascular response to acute angiotensin II inhibition.

摘要

简介

高血压(BP)可导致靶器官损伤。有研究表明,在血压正常化的前提下,早期器官病变有可能逆转。本研究旨在评估原发性高血压(EH)患者在接受强化降压治疗后,血压持续降至推荐值是否会改变多普勒卡托普利试验(DCT)中肾血管对急性血管紧张素Ⅱ抑制的反应。

材料和方法

共 29 人(58 个肾脏)符合研究条件:18 名 EH 患者和 11 名健康志愿者作为对照组。治疗前和强化降压治疗 6 个月后进行肾小球滤过率估计(eGFR)、24 小时动态血压监测(ABPM)和 DCT 检查,评估肾血管阻力指数变化(ΔRI)。强化降压治疗结束时行额外的 ABPM。

结果

平均强化降压治疗时间为 8.5±2.4 个月。EH 组的平均 24 小时收缩压和舒张压在强化降压治疗期间明显低于治疗前和治疗结束时。与治疗前相比,强化降压治疗后,EH 组收缩压和舒张压均显著降低(p<0.05),肾功能明显改善(eGFR 从 121±38 增加到 139±40 ml/min,p<0.001)。在强化降压治疗前,EH 组的 ΔRI 明显低于对照组,但强化降压治疗后,两组间无差异。

结论

EH 患者血压持续降至推荐值可改善肾功能,并使肾血管对急性血管紧张素Ⅱ抑制的反应正常化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d3c/3284067/1caa2c0a8e64/AMS-6-15175-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验